DS
ECYT

David Shaw’s Endocyte, Inc. Common Stock ECYT Stock Holding History

David Shaw’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-105,000
Closed -$1.86M – 4148
2018
Q3 		$1.86M Buy
+105,000
New +$1.8M ﹤0.01% 2248

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

David Shaw's ECYT Position: Q4 2018 in Review

David Shaw sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 74,788 shares — an estimated $1.33M sold.

David Shaw first reported a position in ECYT in Q1 2014 and held it in 18 quarters. The position peaked at $14.7M in Q1 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • David Shaw reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • David Shaw sold 74,788 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $1.33M.
  • David Shaw first reported a position in Endocyte, Inc. Common Stock in Q1 2014 and held it in 18 quarters.
  • David Shaw's Endocyte, Inc. Common Stock position peaked at $14.7M in Q1 2018.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.